BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 3842394)

  • 1. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-induced modulation of human ras oncogene expression.
    Samid D; Schaff Z; Chang EH; Friedman RM
    Prog Clin Biol Res; 1985; 192():265-8. PubMed ID: 2417251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
    Thomassen DG; Gilmer TM; Annab LA; Barrett JC
    Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD; Allen HL; Kraynak AR; Bradley MO
    Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Muschel RJ; Williams JE; Lowy DR; Liotta LA
    Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on reversion of the human activated c-Ha-ras-transformed cells].
    Ogiso Y
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J; Le Chalony C; Prosperi MT; Goubin G
    Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of malignant subcutaneous sarcomas in hamsters by a recombinant DNA containing BK virus early region and the activated human c-Harvey-ras oncogene.
    Corallini A; Pagnani M; Viadana P; Camellin P; Caputo A; Reschiglian P; Rossi S; Altavilla G; Selvatici R; Barbanti-Brodano G
    Cancer Res; 1987 Dec; 47(24 Pt 1):6671-7. PubMed ID: 2824040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming genes in human tumors.
    Pulciani S; Santos E; Lauver AV; Long LK; Barbacid M
    J Cell Biochem; 1982; 20(1):51-61. PubMed ID: 6761348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adeno-associated virus on transformation of NIH 3T3 cells by ras gene and on tumorigenicity of an NIH 3T3 transformed cell line.
    Katz E; Carter BJ
    Cancer Res; 1986 Jun; 46(6):3023-6. PubMed ID: 3009007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat embryo cells immortalized with transfected oncogenes are transformed by gamma irradiation.
    Endlich B; Salavati R; Sullivan T; Ling CC
    Radiat Res; 1992 Dec; 132(3):301-11. PubMed ID: 1475353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
    Lanza LA; Wilson DJ; Ikejiri B; Roth JA; Grimm EA
    J Immunol; 1986 Oct; 137(8):2716-20. PubMed ID: 3489774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
    Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
    Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW; Trimble WS; Hozumi N; Roder JC
    J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental metastatic ability of H-ras-transformed NIH3T3 cells.
    Bondy GP; Wilson S; Chambers AF
    Cancer Res; 1985 Dec; 45(12 Pt 1):6005-9. PubMed ID: 4063960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites.
    Ananthaswamy HN; Price JE; Goldberg LH; Bales ES
    Cancer Res; 1988 Jun; 48(12):3341-6. PubMed ID: 3370635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation of rodent immortalized and embryo cells by oncogenes. I. Mouse (NIH 3T3) and rat (FR 3T3) immortalized fibroblasts.
    Denner J; Ehm I; Jandrig B; Friese D
    Arch Geschwulstforsch; 1987; 57(6):463-74. PubMed ID: 3435225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.